The analysis of the CCSC-derived tumours revealed that FDMC treatment not only restricted tumour growth by inhibiting pluripotency transcription factors (OCT4 and SOX2), inflammation (NF-kB), and angiogenesis (VEGF) but also induced apoptosis (C-PARP). The gene discussed is SOX2; the disease is neoplasm.